Meet theGHB Intellect Team
The Technical Expert Solution for IP Teams
GHB Intellect, a division of GHB Services, LLC, is a full-service IP consulting (Intellectual Property) and engineering services firm with hundreds of expert professionals highly specialized in technology and sciences. Founded by industry veterans and accomplished innovators, GHB Intellect is led by strong, diverse management and advisory teams. Decades of experience, technology & science expertise, and industry connections are leveraged to help IP companies, high-tech corporations, and law firms achieve their goals.
Each of our specialists has deep subject-matter expertise in his/her area of specialty through extensive academic accomplishments (typically a Master’s or PhD degree) and decades of industry and standards practice. We have the know-how and the tools to bring immediate technical insight to your projects and to add substantial value to your business. You can learn more and get a detailed list of some of the technologies and industries we have experience in. We can scale our resources to fit your needs, be it the technical analysis of a patent portfolio, reverse engineering of a product, expert witness testimony, technical assessment & due diligence, or design and development of a technology/product. Learn more about Why GHB Intellect is an industry-leading IP consulting firm.
The individual members of the GHB Intellect management team were carefully chosen in order to ensure that every aspect of intellectual property and engineering expertise was well covered. The expert management team was hand-selected based upon their relationships within the IP community, their extensive educations, and their significant career achievements. We are pleased to share our primary decision makers and their backgrounds. For more information, please reach out to our team today!
Ghobad Heidari, PhD
Founder & President
Dr. Ghobad Heidari has over 25 years of technology research and development, IP analysis, and management experience. His expertise areas include wireless communication systems and standards, consumer electronics, satellite communications, semiconductors, and embedded systems. Since 2007, he has been involved with IP management and analyses, engineering designs and developments, as well as IP litigation support. Previously, he has served as VP of Engineering at various small and large corporations (WiLinx Corp, Olympus Corp) where he researched, developed and standardized various short-range, high-speed wireless communication systems. Prior to that, he held various technical and management positions at Nokia, AT&T, and various startup tech companies.
Dr. Heidari has a PhD from Purdue University, has over 30 granted patents and a multitude of conference and journal papers. He has taught various courses at University of California. He has had extensive experiences with and contributions to various industry standards (3GPP2, IEEE 802.11, Bluetooth, USB-IF, etc.). He is the author of WiMedia UWB for Wireless USB and Bluetooth, John Wiley & Sons, 2008.
For the past five consecutive years, Dr. Heidari has been named one of the World’s Leading IP Strategists by the prestigious IAM Strategy 300. IAM has also named him as a Strategy 300 Global Leader.
Chao Qi, PhD, JD, MBA
Director, IP Management
Dr. Chao Qi is an intellectual property attorney with a deep background in all aspects of patent prosecution and intellectual property counseling, licensing, and litigation. At GHB Intellect, Chao strives to bring his science, legal, and business acumen to the forefront in providing consulting services to a wide range of clients in the information technology, pharmaceutical, biotechnology, and medical device industries.
Prior to joining GHB Intellect, Chao was a patents and innovations and patent litigation attorney at Wilson Sonsini Goodrich & Rosati, where he was involved in several high-stakes trials over pharmaceutical compounds. Chao holds a Ph.D. in Molecular and Cellular Pharmacology from the University of Wisconsin and has over 10 years of research experience in molecular biology, biochemistry, pharmacology, neuroscience, genetics, and behavioral psychology. He obtained his J.D and M.B.A. from the University of Southern California.
Chao has been recognized as an industry leader through his inclusion in IAM Strategy 300. He is further highly dedicated to helping his communities and was previously a recipient of the Casa Cornelia Law Center Pro Bono Publico Award.
荒垣 雅夫 Masao (Mark) Aragaki, MBA
アジア代表 Senior Director, Asia
Aragaki-san has had a long and illustrious career in the high-tech industry, bringing some of the most successful products to various markets around the world. His 37-year long career at Sharp Corporation spanned around the global (Asia, US, Europe). For 13 years, he was with Sharp Electronics in the US, where he led the PC, Tele-Communication, Business Productivity, LCD Display, Medical Equipment, and other high technology business units. Later, he successively headed Sharp UK, Sharp Germany, Sharp Europe, and finally Sharp’s Global Telecommunications unit. The numerous products that he brought to market became leaders in their respective areas.
After Sharp, and prior to joining GHB intellect, Mark was involved in a number of IP and entrepreneurial consulting, helping large and small high-tech companies achieve their business objectives. He received an MBA from Business School Lausanne (Switzerland) after MBA studies at the University of London.
Ryan Heidari, PhD-ABD
Senior Patent Brokering Specialist
Mr. Ryan Heidari (no relation to Dr. Ghobad Heidari) has been involved in intellectual property development, analysis and transactions for over 25+ years. In recent years, he has been helping clients with their IP analysis, strategy, and brokerage requirements. From 2004 to 2015, he served as Director of Product Development at Qualcomm, where he oversaw various marketing operations while establishing competitive product and IP roadmap for the company. His technical expertise and his leadership in various standards led to commercial deployment of many novel technologies & services for Qualcomm.
Prior to Qualcomm, Ryan was a Program Manager at Nokia Mobile Phones for 12 years. He was managing a large group of technical staff and was responsible for the design and implementation of various technologies for Nokia smartphones. His extensive experiences in the industry also include Pitney Bowes, Rockwell International, and Xerox.
Ryan received his PhD-ABD in Electrical Engineering from University of Southern California and his MSEE from San Diego State University. He has been granted many patents and has authored various technical journal articles.
Advisory Board
GHB Intellect’s advisory board is comprised of industry thought leaders in multiple fields and with decades of experience. Their knowledge and expertise contribute immensely to GHB Intellect’s full service IP consulting and litigation support, helping to provide unparalleled value to our clients.
Ross Farahani, PhD
Dr. Farahani received his PhD degree in Materials Science and Engineering in 1980. Over the past 27 years he has been employed by several of the semiconductor industry leaders (United Technologies Mostek, SGS Thompson, AMD, and Intel), where he was instrumental in the development and integration of multiple innovative processes in semiconductors device fabrication and packaging assembly. Many of the processes are still in production. His work experience encompasses interconnect process technology development and integration for DRAM, Flash nonvolatile memory, microprocessor, and high voltage Bipolar. While at AMD, he also managed the integration group responsible for interconnect technology research, development, and integration for high voltage bipolar technology. Dr. Farahani was an AMD Technical Fellow and has numerous publications and patents in semiconductor interconnect metallization.
Graham Beaton, PhD
Dr. Beaton is a life sciences entrepreneur engaged in developing new product opportunities in healthcare and bolsters the GHB Intellect technology development service offering. He is President and co-founder of Epigen Biosciences Inc., a project incubator located in San Diego and co-founder and acting Chief Science Officer at Curtana Pharmaceuticals, an early-stage startup engaged in the discovery and development of novel targeted treatments for glioblastoma and other brain cancers. Dr. Beaton has gained more than 20 years working experience in the healthcare sector with respect to pharmaceuticals and biotechnology from companies including Amgen, DuPont Pharmaceuticals and Neurocrine Biosciences.
Hossein Rahbar, PhD
Prof. Rahbar obtained his PhD degree in Statistics from Michigan State University (MSU) in East Lansing, Michigan, in 1988. In 2008, Dr. Rahbar joined the University of Texas Health Science Center at Houston (UTHealth) as Professor of Epidemiology and Biostatistics in the School of Public Health. He also serves as Director, Biostatistics/Epidemiology/Research Design (BERD) component of Center for Clinical and Translational Sciences (CCTS) at UTHealth. In 2012, Prof. Rahbar was appointed as the founding Director of the Division of Clinical and Translational Sciences (DCTS) in the Department of Internal Medicine at UTHealth.
Currently, he is a tenured professor in Internal Medicine and the School of Public Health. Prof. Rahbar is a member of several professional organizations including Joint Statistical Meeting (JSM), American Statistical Association (ASA), Society of Epidemiological Research (SER), International Society for Autism Research (INSAR), Canadian-USA Clinical Epidemiology Network, Pulmonary Vascular Research Institute. He serves as a member of Advisory Group to the World Health Organization (WHO) regarding Maternal and Perinatal Health Research and Reproductive Epidemiology. He is Editor-in-Chief of American Journal of Autism (AJA) and recipient of several prestigious grant awards from NICHD, NIEHS, NHLBI, NINDS, DoD, and WHO.
Farah Babakhani, PhD
Dr. Babakhani has 20 years of experience in pharmaceutical industry and diagnostic laboratory management. She was a key contributor to the microbiological development of the recently approved Fidaxomicin antibiotic and contributed to pre-clinical development of other anti-infectives. Her contributions have led to several peer-reviewed publications and patent authorships. Prior to working in the pharmaceutical industry, Dr. Babakhani managed a diagnostic clinical microbiology laboratory.
Our team and community are growing continuously. If you are interested in joining, visit our careers page.